SCIESCOPUSQ2
ImmunoTargets and Therapy
DOVE MEDICAL PRESS LTD, New Zealand
ImmunoTargets and Therapy is an academic journal published by DOVE MEDICAL PRESS LTD (New Zealand). Identifiers: eISSN 2253-1556. Indexed in SCIE, SCOPUS. Metrics: JIF 4.4, CiteScore 8.6, SJR 2.291, SNIP 1.53. Subject areas: IMMUNOLOGY. tlooto lists 466 papers from this journal.
CiteScore
8.60
Scopus citation metric
SJR
2.291
SCImago rank
SNIP
1.53
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2253-1556
- Abbreviation
- IMMUNOTARGETS THER
- Publisher
- DOVE MEDICAL PRESS LTD
- Country
- New Zealand
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2403 Immunology2723 Immunology and Allergy
Papers in this journal
Recent papers
- Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG
2026
- The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons.
2026
- Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)
2026
- Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma
2026
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy.
2026
Most cited papers
- Melanoma treatment in review
2018 · 549 citations
- The role of adipokines in chronic inflammation
2016 · 335 citations
- Immunoinformatics and Vaccine Development: An Overview
2020 · 211 citations
- The hygiene hypothesis: current perspectives and future therapies
2015 · 168 citations
- Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
2020 · 156 citations